Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Xiaoaiping Granules
Manufacturer:
Jilin Wantong Pharmaceutical Co., Ltd.
Xiaoaiping Granules
Manufacturer:
Shanghai Huangxiang Tieli Blue Sky Pharmaceutical Co., Ltd.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Anti-cancer Ping Wan
Manufacturer:
Jiangsu Kanion Pharmaceutical Co., Ltd.
Anti-cancer Ping Wan
Manufacturer:
Competent Investments Limited
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Simcere Pharmaceutical Co., Ltd.
Irinotecan Hydrochloride Injection
Indication: This product is suitable for the treatment of patients with advanced colorectal cancer: combined with 5-fluorouracil and folinic acid to treat patients with advanced colorectal cancer who have not received chemotherapy before; as a single drug, to treat patients who have failed chemotherapy containing 5-fluorouracil.
Manufacturer:
Qilu Pharmaceutical (Hainan) Co., Ltd.
Doxifluridine Tablets
Indication: This product is used for gastric cancer, colon cancer, rectal cancer, breast cancer, cervical cancer, and bladder cancer.
Manufacturer:
Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
Enteral Nutrition Suspension (SP)
Indication: This product is suitable for patients with gastrointestinal function or partial gastrointestinal function who cannot or are unwilling to eat enough regular food to meet the body's nutritional needs. It is mainly used for: 1. Metabolic gastrointestinal dysfunction, pancreatitis, intestinal inflammatory diseases, radiation enteritis and chemotherapy, intestinal cancer, short bowel syndrome, HIV/AIDS. 2. Critical illness, large area burns, trauma, septicemia, and recovery period after surgery. 3. Preoperative feeding of malnourished patients 4. Intestinal preparation This product can be used for diabetic patients.
Manufacturer:
Nutricia Pharmaceutical (WUXI) Co., Ltd.
Xiao'anping chewable tablets
Manufacturer:
Nanjing Lifecare Pharmaceutical Co., Ltd.
Related Ingredients
-
1,10-Phenanthroline hydrate list
5144-89-8 -
Oxaliplatin list
61825-94-3 -
Cinobufagin list
470-37-1 -
Irinotecan hydrochloride list
100286-90-6 -
Doxifluridine list
3094-09-5